Article · Journal · 2023

The expanding role of gene-based prescribing for phase II drug-metabolizing enzymes

American Journal of Pharmacotherapy and Pharmaceutical Sciences

Citations: 2from other works
Field-weighted impact: 0.411.00 is the world average for its field and year
Among its field: 65th percentileby citations, against works of its field and year
Authors: 3from 2 institutions

Authors

3 authors across 2 institutions in 2 countries

Chinedum Peace BabalolaFirst author
- University of Ibadan (NG)
as printed: Chinedum P. Babalola
Olayinka Adejoke Kotila
- University of Ibadan (NG)
as printed: Olayinka Kotila
Otito Frances IwuchukwuSenior authorCorresponding